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Abstract:  
Aims: Adenosine can induce splenic vasoconstriction (splenic switch off). In this study 
we aim to evaluate the utility of identifying a lack of splenic switch off for detecting false 
negative adenosine stress perfusion cardiac magnetic resonance (CMR) scans. 
Methods and Results: We visually analysed 492 adenosine stress perfusion CMR scans 
reported as negative in a cohort of patients with no previous history of coronary artery 
disease. A lack of splenic switch-off was identified in 11%. We quantified the 
phenomenon by drawing regions of interest on the spleen and comparing intensity 
between stress and rest scans, the spleen intensity ratio (SIR). Inter-rater agreement for 
qualitative determination of splenic switch off was κ=0.81 and inter-class correlation for 
quantitative determination of splenic switch off was 0.94. The optimal threshold for SIR 
as an indicator of splenic switch off was 0.40 (sensitivity = 82.5%, specificity=92.3%, 
AUC=0.91). 23065 CMR scans and 9926 invasive coronary angiogram reports were 
retrospectively examined to identify patients with negative CMR scans who required 
coronary intervention in the subsequent 12 months (false negatives). We compared 
these scans with true positives who had positive adenosine stress perfusion CMR scans 
followed by coronary intervention. The rate of lack of splenic switch off was 20.7% in 
the false negative group versus 13.1% in true positives (p=0.37). 
Conclusion: Lack of splenic switch off is prevalent, easily measureable and has potential 
to improve on haemodynamic criteria as a marker of adenosine understress in CMR 
perfusion scans. 
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Introduction  
The presence of myocardial ischaemia during functional imaging of the heart is 
independently associated with an increase in cardiac death and non-fatal 
complications1. In contrast, the absence of ischaemia appears to carry a very favourable 
prognosis for cardiovascular mortality and morbidity2. As such, functional testing for 
ischaemia forms a major part of current guidelines for both diagnosis and risk-
stratification in stable coronary artery disease (CAD)3,4. 
Stress perfusion cardiovascular magnetic resonance (CMR) provides a non-invasive 
means for the evaluation of ischaemia. Meta-analyses have consistently shown a 
sensitivity of 89% and a specificity of around 80% in detecting angiographically 
significant CAD5 6. Adenosine is the most prevalent stressor in stress perfusion CMR5. 
The use of CMR has increased in recent years and is now a valuable tool in routine 
clinical management7. 
However, a false-negative rate of up to 10% has been reported for adenosine stress-
perfusion CMR when compared to quantitative coronary angiography. More than a third 
of these false-negative results may be a result of inadequate pharmacological stressing 
with adenosine8, producing insufficient vasodilation to unmask functionally significant 
perfusion abnormalities.  
The currently accepted protocol for adenosine studies relies on administration of a fixed 
dose of the stressor, with uptitration if there is failure to reach pre-specified 
physiological targets (heart rate increase by 10 beats per minute, drop in systolic blood 
pressure and/or the experience of physical symptoms associated with adenosine 
administration)9. These targets carry a risk of misclassification of a study as adequately 
stressed for several reasons. First, reporting of symptoms is subjective and even with no 
adenosine present there can be non-specific changes in heart rate during 
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testing.  Second, a drop in blood pressure is not significantly associated with adenosine 
administration10. Third, changes in myocardial blood flow and coronary vascular 
resistance correlate poorly with changes to peripheral haemodynamics (heart rate and 
non-invasive blood pressure) in response to adenosine11. Finally, inadequate stressing 
may result from pharmacological interactions of adenosine with caffeine, 
methylxanthines, smoking, antidepressants and a host of related substances the patient 
may be taking12. 
Manisty et al have previously described adenosine-induced splenic vasoconstriction 
(splenic switch-off, SSO), manifest as decreased brightness of the spleen during 
adenosine stress perfusion CMR. They showed that rates of lack of SSO were 
significantly higher in subjects with proven false negative studies than in those with true 
negative studies, in the large CE-MARC study comparing SPECT and adenosine perfusion 
CMR for detection of angiographically significant coronary disease13. 
In this retrospective observational study, we assessed the prevalence, ease of 
measurement and reproducibility of SSO in a real-world and diverse cohort of patients 
presenting to a tertiary referral centre in London, UK.  
In a second retrospective cohort, we aimed to assess the prognostic value of SSO. We 
carried out a case-control study to assess whether patients with a negative stress 
perfusion CMR who required coronary angiography and/or percutaneous intervention 
within a year after the scan were more likely to have had an under-stressed study, as 
determined by SSO.  
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Methods  
MRI Protocol  
All scans were performed in a single centre (London Chest Hospital, part of Barts 
Health) using a 1.5T MR scanner (Achieva CV, Philips Healthcare, Best, The 
Netherlands). All patients had been asked to refrain from caffeine for 12 hours prior to 
their scan.  Intravenous adenosine was infused at 140 μg/kg/min for 3 minutes with 
continuous heart rate recording, with uptitration to 175 μg/kg/min if there was failure 
to reach pre-specified physiological targets (heart rate increase by 10 beats per minute, 
drop in systolic blood pressure and/or the experience of physical symptoms associated 
with adenosine administration). For the purposes of this study, the patients’ 
haemodynamic responses were defined as adequate if they demonstrated a heart rate 
increase >=10bpm. Following this, an intravenous bolus of 0.05 mmol/kg of gadoteric 
acid was administered. 3 short axis slices, each of 10 mm thickness, were acquired per 
cardiac cycle during free-breathing, at the basal, mid and apical levels of the left 
ventricle. The same perfusion sequence parameters were used for stress then rest 
perfusion for all patients: single-shot balanced steady -state free precession (bSSFP) 
sequence (TR 2.6 ms TE 1.3 ms, flip angle 50 ̊), typical  acquired voxel size of 2.8 × 2.9 
mm2 (readout × phase encoding) and a typical matrix size of 108 × 117 (readout × phase 
encoding). A 90o saturation preparation RF pulse was applied prior to every acquired 
slice with a saturation delay time of 100 ms. A parallel imaging acceleration factor of 2.3 
was also used (sensitivity encoding (SENSE)) to reduce slice acquisition time. 
 
Validation cohort 
We sought to investigate the prevalence of SSO and evaluate the demographic and 
haemodynamic predictors of SSO in a cohort of patients undergoing adenosine stress 
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perfusion CMR for the investigation of chest pain of recent onset between 2008 and 
2011.   
As such, we retrospectively identified 503 consecutive patients with no previous history 
of coronary artery disease (diagnosis of angina, previous acute coronary syndrome or 
heart failure) or any imaging findings suggestive of underlying cardiac disease (scan 
reported as normal with ejection fraction >50%, no late gadolinium enhancement and 
no severe valvular defects) who had a stress perfusion scan which was reported as 
negative (i.e. no adenosine induced perfusion defects detected).   
Basic demographic data were extracted from electronic patient records and the cohort’s 
heart rate response to the adenosine bolus was extracted from the DICOM meta-data. As 
per protocol, a heart rate increase of >= 10 beats per minute was considered a marker of 
adequate stressing.  
 
Visual Analysis of SSO 
All scans were analysed by two independent observers for the presence of SSO (see 
Figure 1). In the rest image the splanchnic circulation is vasodilated; following the 
administration of adenosine there is splanchnic vasoconstriction and therefore when 
gadolinium contrast is administered, the spleen has reduced signal intensity compared 
to with resting perfusion imaging. SSO is a graded and transitory response which can be 
assessed visually on comparison of the rest and stress perfusion images.  Therefore, we 
defined the filling of the left ventricle as time zero to ensure synchronous comparison of 
rest and stress scans. Any disagreement in the visual analysis was resolved by an 
experienced third observer (>10 years of experience).   
 
Quantitative analysis of SSO 
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In addition, a subgroup of 252 scans were analysed quantitatively by the two observers 
using cvi42(cvi42 v5.1, Circle Cardiovascular Imaging Inc., Calgary, Canada). A region of 
interest (ROI) was selected on the slice with the spleen most clearly visible and 
propagated through the whole scan for the first 30 seconds on both rest and stress 
images. The ratio between the brightest mean signal intensity of the ROI between stress 
and rest images, adjusted for baseline (pre-contrast) signal intensity, gave a single 
parameter - the spleen intensity ratio (SIR).    
Case control study  
To ascertain whether lack of SSO is associated with the need for invasive coronary 
angiography, we identified as our cases all patients who presented between 2008-2014 with a 
negative adenosine stress perfusion CMR scan who later required coronary intervention 
within one year of their scan. The control inclusion criterion was patients who had a positive 
adenosine stress perfusion scan followed by coronary angiography with intervention within a 
year of their scan). From this control group we age- and gender- matched controls in a ratio of 
2 controls per 1 case, using nearest neighbour matching without replacement. Cases and 
controls with missing image data were excluded. Figure 4 shows the flowchart of selection of 
cases and controls from the 23065 CMR scans and 9926 coronary angiographies  
Blinded visual assessment for the presence of SSO in cases and controls was performed 
by two independent assessors, with disagreements again resolved by the experienced 
third observer.  
 
 
Statistical analysis 
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All continuous data are expressed as mean (± SD). All continuous baseline 
characteristics were assessed using student’s t-test and categorical characteristics were 
compared using Fisher’s exact test.  
Inter- and intra-observer agreement for the visual identification of SSO was analysed 
using Cohen’s kappa with repeat analysis after three weeks (n=50).  
Inter-observer agreement for quantitative measurements was assessed by the inter-
class correlation coefficient. Bland Altman plots were constructed to assess for the 
presence of systematic bias in quantitative measurements of SSO using a random sample 
of cases. To find out the SIR that best correlated to visual discrimination of SSO, we 
constructed a receiver operator curve (ROC). 
To investigate the association of SSO with haemodynamic and demographic parameters, 
a logistic regression model using a generalised linear model with a logit link function 
was used. Age was expressed as a discretized continuous variable (less than 60 versus 
60 or greater years old), and ethnic groups were categorized as white, Asian, black and 
others/not stated. Haemodynamic response was defined as above. A logistic regression 
model was also used to examine the relationship of pharmacological understressing and 
need for coronary intervention at one year. Basic demographic variables as well as 
clinically important covariates were examined for inclusion in the model using a 
stepwise selection method (history of hypertension, hypercholesterolaemia, diabetes 
mellitus, smoking, systolic dysfunction, previous percutaneous coronary intervention, 
previous myocardial infarction, previous CABG and family history of coronary artery 
disease).  Differences were deemed significant at the p<0.05 level.  
All statistical analyses were performed using R (R: A language and environment for 
statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL 
http://www.R-project.org/). 
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Results  
Baseline Characteristics 
The baseline characteristics of both cohorts are presented in tables 1 and 2. Our 
validation cohort represents a realistic sample of the population this tertiary centre 
serves, with the two most prevalent ethnicities being White and Asian. 50.1% of patients 
were male. Our case control cohort is well matched for age and gender. Cases and 
controls differed significantly for prevalence of previous CABG and family history of 
CAD. Indication for angiography was management of ACS in 20.4%, and the remainder 
was for stable angina. All proceeded to angioplasty ± stenting according to clinical 
indication. 
 
Validation cohort 
For the validation cohort, six scans (1.2%) were excluded due to poor quality and 5 
(1%) had no visible spleen. A lack of SSO occurred in 11.0% of scans (53/492) when 
assessed qualitatively.  Inter-rater agreement for visual, qualitative assessment of SSO 
was excellent with κ=0.81; intra-rater agreement was also good, with κ=0.70.   
 
For quantitative measurements, the mean SIR was 0.31 and the interquartile range 0.15 
to 0.40. The inter-class correlation coefficient between observers was 0.94, and the 
Bland-Altman plot (Figure 2) shows good agreement across a range of SIRs without 
systematic bias for a random sample of cases (n= 50, bias=0.00248, limits of 
agreement=-0.162 – 0.157, arbitrary units a.u.).  
Using visual assessment as the reference standard, ROC analysis showed that the 
optimal threshold for the SIR as an indicator of SSO, giving equal weight to specificity 
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and sensitivity (the point closest to the upper left corner) was 0.40 (sensitivity = 82.5%, 
specificity=92.3%, AUC=0.91). (Figure 3) 
 
People with a lack of SSO were more likely to be white (p<0.001). Age and gender did 
not appear to influence SSO rates significantly (table 3). The presence of a 
haemodynamic response more than halved the odds of observing a lack SSO (OR=0.45), 
even after adjusting for age, gender and ethnicity in our multivariate model. However, a 
significant proportion of people had a lack of SSO, despite having a haemodynamic 
response (66.0%). Similarly, many people who had SSO did not have haemodynamic 
response (18.0%) (table 4). 
 
Case control study 
To ascertain whether lack of SSO is associated with need for invasive coronary 
angiography, we obtained a database of all 23065 CMR scans and 9926 coronary 
angiographies performed during the study period. The identification of cases and 
controls is shown in Figure 4. 1622 patients had both a CMR study and an angiogram. Of 
those 231 had an adenosine stress perfusion followed by an angiogram within 12 
months. 31 of the above patients had a negative study followed by angiography (29 
scans available). These cases were age and gender matched with 62 control patients 
(positive CMR scans followed by angiography, 60 scans available). All 93 angiographies 
proceeded to angioplasty. 
 
Overall, 15.7% of patients had a lack of SSO.  There were fewer cases of SSO in those 
with false negative stress scans compared to positive stress scans, but this difference 
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was not statistically significant (20.7% vs 13.1% of positive scans, p=0.37). In our 
multivariate model, no covariates reached statistical significance. 
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Discussion 
We have validated the phenomenon of SSO in a real-world cohort of patients. Visual and 
quantitative assessment of SSO is consistent and reproducible. SSO is only weakly 
associated with haemodynamic response, which corroborates with other studies 
showing that the hyperaemic and haemodynamic response to adenosine correlate 
poorly14. We believe SSO is a better indicator of adequate adenosine stress than heart 
rate response, based on previous observations and experimental data that show a good 
correlation of the myocardial hyperaemic response to adenosine with the splanchnic 
vasoconstrictor response15. Up to 23% of patients could have a misclassified response 
by current haemodynamic methods; SSO may reduce this rate.  
 
Our case control study allowed us to compare rates of SSO in those with positive CMR 
perfusion scans and negative CMR perfusion scans, in patients who required 
revascularization within a year. Out of 23065 scans, we found only 231 patients (1%) 
who required an angiogram within 1 year of a CMR stress scan.  
 
In the case control cohort, we observed a more frequent lack of adenosine response (no 
SSO) in patients with no perfusion defect on CMR, compared to those with a perfusion 
defect on CMR (absolute difference of 7.6%) but this was not statistically significant 
likely due to small sample size and resultant lack of statistical power. If this observation 
held true in a larger cohort, SSO could be considered a good marker for false negative 
scans. Furthermore, identifying a larger cohort of cases would allow us to have the 
statistical power in assessing whether use of lack of SSO has any incremental value over 
the assessment of haemodynamic responses in predicting the need for coronary 
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intervention as well as examining whether the combination of both SSO and 
haemodynamic response assessment can yield a reduction in false negative scans. 
 
Our validation cohort comprised a retrospective sample drawn from a 
socioeconomically and ethnically diverse area, presenting for the evaluation of 
suspected ischaemic heart disease. Compared to the case control cohort our validation 
sample was younger, had a higher proportion of female patients and had no previous 
adverse cardiovascular events. The case control cohort represents a group of patients 
with significant cardiovascular risk factor burden, who all required coronary 
intervention within a year. 88% had at least one of hypertension, 
hypercholesterolaemia, diabetes mellitus or had ever smoked; 68% had at least two of 
these risk factors. Thus, we noted with interest the higher rate of a lack of SSO in the 
case control cohort compared to the validation cohort (15.7% vs 11%).   
 
The case control cohort may have been on treatments that would modify the response to 
adenosine. However, their risk factors may themselves affect haemodynamic response 
to adenosine. The A1 adenosine receptor responsible for splenic vasoconstriction is also 
complicit in insulin resistance and the downregulation of adenosine receptors has been 
implicated in insulin insensitivity16. Hypercholesterolaemia, chronic hypertension and 
family history have also been linked to attenuated vascular response to adenosine, both 
in cellular and in-vivo studies17, 18. This could also explain why our false negative rate is 
higher than that in CE-MARC7. Our cohort includes patients with previous coronary 
artery bypass grafts, previous myocardial infarction and patients presenting with acute 
coronary syndrome that were excluded from CE-MARC. 
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Our study results have to be interpreted in the context of the study design. The 
validation and case-control cohorts are from very different populations and thus limit 
the extent to which our data can be generalised. Although we had relatively complete 
risk factor profile in the case control cohort, we did not have a complete medication 
history. In particular, aminophylline and caffeine attenuate the effect of adenosine, and 
may account for some false negatives19, 20. Patients were asked to refrain from caffeine 
for 12 hours before their appointment, but compliance rates are unknown. Patients may 
not be entirely at fault with non-compliance, as drinks advertised as decaffeinated can 
contain significant quantities of caffeine21. Other vasodilators, such as nitrates and 
calcium-channel blockers, could interfere with haemodynamic response to adenosine. 
 
In summary, we have shown that lack of SSO is prevalent, easily measureable and has 
potential to improve on haemodynamic criteria as a marker of adenosine understress in 
CMR perfusion scans. The radiographer and clinician should keep the marker in mind 
when acquiring and reporting scans. Further work could combine SSO with 
haemodynamic response to further minimize false negative rates. 
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Text tables 
Table 1: Baseline characteristics of the validation cohort. 
N 503 
Able to assess SSO 492 
Age (standard deviation) 59.1 
(13.6) 
Male 50.4% 
(248) 
Ethnicity: 
White (English, Scottish, Welsh, Irish, 
Other) 
27.8% 
(137) 
Asian (Pakistani, Indian, Bangladeshi, 
Other, Chinese) 
23.3% 
(115) 
Black (African, Caribbean, Other) 
 
6.30% 
(31) 
Other 6.71% 
(33) 
Not stated 35.8% 
(176) 
SSO= Splenic switch-off 
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Table 2: Baseline characteristics of case control cohort. 
  
Negative 
Scan (n=31) 
Positive Scan 
(n=62) 
p-
value  
Age 66 66 0.97  
CABG 6.45% 21.0% 0.08  
Hypercholesterolaemia 63.3% 63.3% 1  
DM 25.8% 35.5% 0.35  
EF <50% 22.6% 21.0% 0.85  
FHx 45.2% 16.7% 0.003  
HTN 76.7% 70.7% 0.73  
Male 71.0% 72.6% 0.87  
Previous MI 38.7% 40.3% 0.88  
Previous PCI 41.9% 33.9% 0.45  
Smoker 48.4% 46.8% 0.88  
CABG=Coronary Artery By-pass Grafting, DM= Diabetes Mellitus, EF= Ejection Fraction, 
FHx=Family History, HTN= Hypertension, MI= Myocardial Infarction, PCI= Percutaneous 
Coronary Intervention 
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Table 3: Univariate and multivariate regression analyses for predicting splenic switch-off 
in the validation cohort. 
 
 Univariate regression Multivariate regression 
Predictor Odds ratio p-value Odds ratio p-value 
Male gender 0.62 (0.34 - 1.09) 0.10 0.60 (0.32-
1.10) 
0.10 
Adequate 
haemodynamic 
response 
2.61 (1.39- 4.76) <0.01 2.43 (1.27-
4.57) 
<0.01 
White ethnicity 0.27 (0.15-0.48) <0.001 0.25 (0.14-
0.46) 
<0.001 
Asian ethnicity 1.92 (0.89- 4.76) 0.12   
Age (over 60 vs 
under 60 years 
old) 
0.78 (0.44-1.38) 0.40   
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Table 4: Comparison of SSO and haemodynamic response rates in the validation cohort 
(n=492, p<0.01). 
 Haemodynamic response No haemodynamic 
response 
SSO 360 (82.0%) 79 (18.0%) 
No SSO 35 (66.0%) 18 (34.0%) 
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Figure legends 
 
Fig 1: Example of splenic switch-off 
Panels A and B show rest and stress scans respectively, from a patient with SSO. Panels C 
and D show rest and stress scans from a patient with no SSO. The red contour shows signal 
intensity in the spleen and the orange contour shows signal intensity in the blood pool, 
used for baseline adjustment. 
 
 
Fig 2 Bland-Altman plot of interobserver agreement for a random sample of 50 cases. 
Bland-Altman plot for a random sample of 50 cases (for clarity of graphical 
representation) from the validation cohort shows good interobserver agreement (intra-
class Correlation Coefficient=0.94). There was no evidence of random or systematic bias 
(mean of differences= 0.00248, 95%CI (+0.157, -0.162))  
 
Figure 3 Receiver Operator Characteristic curve for threshold determination of 
quantitative measurement of SSO  
Using qualitative evaluation as the gold standard allows cut-off value determination for 
SIR in detecting SSO.  For cut-off of 0.4 AUC=91.8%, sensitivity=82.5%, specificity=92.3%. 
 
Figure 4 Flow chart showing identification of cases and controls. 
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